-
Sector Analysis
Asia-Pacific (APAC) LED Lighting Market Summary, Competitive Analysis and Forecast to 2028
LED Lighting in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - LED lamps or luminaires are long-lasting and provide quality lighting than fluorescent or compact fluorescent or halogen incandescent or incandescent light bulbs. In LED lighting, LEDs are incorporated into lamps and luminaires for general...
-
Sector Analysis
South America LED Lighting Market Summary, Competitive Analysis and Forecast to 2028
LED Lighting in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - LED lamps or luminaires are long-lasting and provide quality lighting than fluorescent or compact fluorescent or halogen incandescent or incandescent light bulbs. In LED lighting, LEDs are incorporated into lamps and luminaires for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Refractory Multiple Myeloma Drug Details: Afatinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Esophageal Cancer Drug Details: Afatinib dimaleate (Giotrif, Gilotrif,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Lymphoma Drug Details: Afatinib dimaleate (Giotrif, Gilotrif, Xovoltib)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afatinib Dimaleate in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afatinib Dimaleate in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afatinib Dimaleate in Cutaneous Squamous Cell Carcinoma...
-
Sector Analysis
Middle East and Africa (MEA) LED Lighting Market Summary, Competitive Analysis and Forecast to 2028
LED Lighting in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 19-3., and forecast to 28). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - LED lamps or luminaires are long-lasting and provide quality lighting than fluorescent or compact fluorescent or halogen incandescent or incandescent light bulbs. In LED lighting, LEDs are incorporated into lamps and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plixorafenib in Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plixorafenib in Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plixorafenib in Glioma Drug Details: FORE-8394 (PLX-8394) is under development for the treatment...
-
Analyst Opinions
Non-Alcoholic Beverages Demand Spaces and Top Trends – Industry Insights
"Industry Insights: Non-Alcoholic Beverages Demand Spaces and Top Trends" explores upcoming trends in the global market for non-alcoholic beverages and their demand spaces. Demand spaces are an iteration of the longstanding analytical mode based around the "five Ws": the who, what, when, where, and whys of consumer attitudes and behaviors. The report includes seven trends which are connected to GlobalData's TrendSight's mega trends which capture and explain consumer preferences and changes within them. There are seven global trends, such as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Neuroendocrine Tumors report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Neuroendocrine Tumors Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...